Sherlock Biosciences’ founding CEO steps down as startup expands mission

Just over a year after Sherlock Biosciences won the first-ever U.S. Food and Drug Administration approval for any CRISPR-based technology, the startup’s co-founder and CEO, Rahul Dhanda, is stepping down.